Literature DB >> 17352993

To treat or not to treat, that is the question: proceedings of the Quebec symposium for the treatment of osteoporosis in long-term care institutions, Saint-Hyacinthe, Quebec, November 5, 2004.

Gustavo Duque1, Louise Mallet, Ayanna Roberts, Serge Gingrass, Richard Kremer, Louis-Georges Sainte-Marie, Douglas P Kiel.   

Abstract

OBJECTIVES: Patients in long-term care institutions (LTCI) are especially at risk for osteoporotic fractures owing to their lack of mobility, poor nutrition, and limited sun exposure. Previous reports have shown that osteoporosis is underdiagnosed and undertreated in LTCI despite the high incidence of osteoporotic fractures in these settings. This document has been developed to assist clinicians practicing in LTCI with the diagnosis and treatment of osteoporosis in their institutionalized patients. These proceedings offer an overview of the particular characteristics of patients at LTCI. Management strategies include both nonpharmacological and pharmacological interventions for the prevention and treatment of osteoporotic fractures in very frail older subjects. PARTICIPANTS: This guide is an edited review of presentations and discussions held by specialists in osteoporosis in the elderly together with physicians and pharmacists practicing in LTCI in the province of Quebec. This symposium was held in Saint-Hyacinthe, Quebec on November 5, 2004. VALUES: The value of a given diagnostic test or treatment option was determined based on the clinical experiences and opinions of the participants and a review of the literature from an evidence-based perspective. RECOMMENDATIONS: All patients located at LTCI are at potential risk for osteoporotic fractures. Global interventions should include vitamin D, calcium, and a comprehensive exercise program. In patients who are at high risk for osteoporotic fractures or with previous fractures, pharmacological treatment should be started. VALIDATION: These recommendations were approved during the final plenary of the symposium. All the prevailing opinions were summarized and included in this article.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17352993     DOI: 10.1016/j.jamda.2006.12.010

Source DB:  PubMed          Journal:  J Am Med Dir Assoc        ISSN: 1525-8610            Impact factor:   4.669


  7 in total

1.  Individuals with neurological diseases are at increased risk of fractures within 180 days of admission to long-term care in Ontario.

Authors:  Micaela Jantzi; Amy C Maher; George Ioannidis; John P Hirdes; Lora M Giangregorio; Alexandra Papaioannou
Journal:  Age Ageing       Date:  2014-11-14       Impact factor: 10.668

2.  Correlations of nursing home characteristics with prescription of osteoporosis medications.

Authors:  Seema Parikh; M Alan Brookhart; Margaret Stedman; Jerry Avorn; Helen Mogun; Daniel H Solomon
Journal:  Bone       Date:  2011-02-21       Impact factor: 4.398

Review 3.  Vitamin D supplementation in older adults: searching for specific guidelines in nursing homes.

Authors:  Y Rolland; P de Souto Barreto; G Abellan Van Kan; C Annweiler; O Beauchet; H Bischoff-Ferrari; G Berrut; H Blain; M Bonnefoy; M Cesari; G Duque; M Ferry; O Guerin; O Hanon; B Lesourd; J Morley; A Raynaud-Simon; G Ruault; J-C Souberbielle; B Vellas
Journal:  J Nutr Health Aging       Date:  2013-04       Impact factor: 4.075

4.  Nutritional impact of elevated calcium transport activity in carrots.

Authors:  Jay Morris; Keli M Hawthorne; Tim Hotze; Steven A Abrams; Kendal D Hirschi
Journal:  Proc Natl Acad Sci U S A       Date:  2008-01-17       Impact factor: 11.205

5.  Osteoporosis management among residents living in long-term care.

Authors:  L M Giangregorio; M Jantzi; A Papaioannou; J Hirdes; C J Maxwell; J W Poss
Journal:  Osteoporos Int       Date:  2009-02-10       Impact factor: 4.507

6.  Cachexia and aging: an update based on the Fourth International Cachexia Meeting.

Authors:  J E Morley; S D Anker; W J Evans
Journal:  J Nutr Health Aging       Date:  2009-01       Impact factor: 4.075

7.  Effectiveness of antiresorptive agents in the prevention of recurrent hip fractures.

Authors:  S Morin; E Rahme; H Behlouli; A Tenenhouse; D Goltzman; L Pilote
Journal:  Osteoporos Int       Date:  2007-07-19       Impact factor: 4.507

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.